Werdan K - Search Results

1

Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model.

Werdan K, Müller-Werdan U. Werdan K, et al. Mol Cell Biochem. 1996 Oct-Nov;163-164:291-303. doi: 10.1007/BF00408670. Mol Cell Biochem. 1996. PMID: 8974069 Review.

2

The impact of insulin-like growth factor-1 on the pattern of cardiac elongation factor-2 variants in a model of overload.

Jäger D, Müller-Werdan U, Pönicke K, Holtz J, Werdan K, Müller SP. Jäger D, et al. Among authors: werdan k. Mol Cell Biochem. 2002 Jan;229(1-2):25-34. doi: 10.1023/a:1017982724938. Mol Cell Biochem. 2002. PMID: 11936844

3

Endogenous ADP-ribosylation of elongation factor-2 by interleukin-1β.

Jäger D, Werdan K, Müller-Werdan U. Jäger D, et al. Among authors: werdan k. Mol Cell Biochem. 2011 Feb;348(1-2):125-8. doi: 10.1007/s11010-010-0646-8. Epub 2010 Nov 19. Mol Cell Biochem. 2011. PMID: 21088871

4

Partial inhibition of protein synthesis by Pseudomonas exotoxin A deranges catecholamine sensitivity of cultured rat heart myocytes.

Müller-Werdan U, Pfeifer A, Hübner G, Seliger C, Reithmann C, Rupp H, Werdan K. Müller-Werdan U, et al. Among authors: werdan k. J Mol Cell Cardiol. 1997 Feb;29(2):799-811. doi: 10.1006/jmcc.1996.0324. J Mol Cell Cardiol. 1997. PMID: 9140836

5

Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity.

Müller-Werdan U, Schumann H, Fuchs R, Reithmann C, Loppnow H, Koch S, Zimny-Arndt U, He C, Darmer D, Jungblut P, Stadler J, Holtz J, Werdan K. Müller-Werdan U, et al. Among authors: werdan k. J Mol Cell Cardiol. 1997 Nov;29(11):2915-23. doi: 10.1006/jmcc.1997.0526. J Mol Cell Cardiol. 1997. PMID: 9405166

6

Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles.

Müller-Werdan U, Schumann H, Loppnow H, Fuchs R, Darmer D, Stadler J, Holtz J, Werdan K. Müller-Werdan U, et al. Among authors: werdan k. J Mol Cell Cardiol. 1998 May;30(5):1027-36. doi: 10.1006/jmcc.1998.0667. J Mol Cell Cardiol. 1998. PMID: 9618243

7

Cardiodepression by tumor necrosis factor-alpha.

Müller-Werdan U, Engelmann H, Werdan K. Müller-Werdan U, et al. Among authors: werdan k. Eur Cytokine Netw. 1998 Dec;9(4):689-91. Eur Cytokine Netw. 1998. PMID: 9889417 Free article. Review.

8

[Septic circulatory shock and septic cardiomyopathy].

Werdan K, Hettwer S, Bubel S, Oelke A, Hoke RS, Wimmer R, Ebelt H, Müller-Werdan U. Werdan K, et al. Internist (Berl). 2009 Jul;50(7):799-800, 802-6, 808-9. doi: 10.1007/s00108-008-2286-6. Internist (Berl). 2009. PMID: 19499195 Review. German.

9

Xenoreactive natural antibodies and induced antibodies--their effects of beating cardiomyocytes as a model of a xenograft.

Müller-Werdan U, Koidl B, Autenrieth A, Klein D, Werdan K, Hammer C. Müller-Werdan U, et al. Among authors: werdan k. Mol Cell Biochem. 1996 Jul-Aug;160-161:315-23. doi: 10.1007/BF00240065. Mol Cell Biochem. 1996. PMID: 8901489

10

The ageing heart: influence of cellular and tissue ageing on total content and distribution of the variants of elongation factor-2.

Jäger D, Holtz J, Redpath NT, Müller SP, Pönicke K, Heinroth-Hoffmann I, Werdan K, Müller-Werdan U. Jäger D, et al. Among authors: werdan k. Mech Ageing Dev. 2002 Jul;123(10):1305-19. doi: 10.1016/s0047-6374(02)00040-4. Mech Ageing Dev. 2002. PMID: 12297334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters